Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRATO-ACS-2: Atorvastatin vs Rosuvastatin for CI-AKI in NSTE-ACS
NCT01870804Phase 4Completed
- Sponsor
- Centro Cardiopatici Toscani
- Start
- May 2013
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, rosuvastatin in acute coronary syndrome (ACS), sponsored by Centro Cardiopatici Toscani. Started May 2013; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01870804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01870804.